The Scientific Committees for the 9th World Congress of Melanoma (WCM) and the 14th International Congress of the Society for Melanoma Research (SMR) invites authors to submit their abstracts for oral and poster presentation. Do not miss this opportunity to present your original research on melanoma at this joint congress meeting. Abstract submissions will only be accepted using the online portals.
Abstract submission for the World Congress of Melanoma program is now open until 28 May 2017. Please select one category from the abstract topics that best describes the content of your abstract. Please note that the Scientific Committee will make the final decision.
Abstract submission for The Society for Melanoma Research (SMR) will be open from 10 April 2017 through to 12 June 2017. Abstract topics for SMR submissions are described below. The SMR abstract submission portal will be available from this page and the SMR website.
Authors are requested to submit abstracts only once for the joint congress using either the World Congress of Melanoma OR the Society for Melanoma Research portal.
Please note that the acceptance of your abstract does not include congress registration. We kindly ask for at least one author (the first or the presenting author) to register for the congress.
WCM ABSTRACT SUBMISSION CATEGORIES
- Early diagnosis
- Health economics
- Surgical issues
Merkel Cell Carcinoma
SMR ABSTRACT SUBMISSION CATEGORIES
- Epigenetics and metabolism
- Genetics and genomics
- Melanoma and melanocyte biology
- Targeted therapy
- Tumour heterogeneity and plasticity
- Tumour microenvironment
- Drug resistance
Abstract text is limited to 4,000 characters
Abstracts must be submitted in English
Please structure your abstract as follows:
Up to 2 tables and 2 graphics/pictures can be used
All abstracts must contain original work that has not been published or presented on previous occasions
Please indicate your preferred type of presentation (oral or poster) and choose a topic from the drop-down list
Please check spelling and grammar carefully. All abstracts will be published as submitted
Use generic names. Commercial drug names may not be used
For SMR abstract submissions, please refer to the SMR website for instructions.
Oral presentation or poster
Submitted abstracts will be carefully reviewed. The scientific committee will decide on the acceptance of abstracts. Notifications of acceptance will be sent in writing.
WCM abstract submissions – notification to authors by mid-June 2017.
SMR abstract submissions – notification to authors by beginning of July 2017.
Nora Charlotte Pohlan
MCI Deutschland GmbH
MCI | Germany – Berlin
10117 Berlin, Germany
+49 30 20459359
+49 30 2045950
Society for Melanoma Research/
Site Solutions Worldwide
1023 Route 146
Clifton Park, New York 12065
+1 518 9302676
+1 518 3993033